董事介绍
注：董事持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Kenneth C. Bockhorst | 男 | Lead Independent Director | 53 | 24.65万美元 | 6.99 | 2026-05-13 |
| Kenneth C. Bockhorst | 男 | Lead Independent Director | 53 | 未披露 | 未持股 | 2026-05-13 |
| Robert A. Cascella | 男 | Independent Director | 71 | 未披露 | 未持股 | 2026-05-13 |
| Thomas D. Logan | 男 | Chairman of the Board,Chief Executive Officer and Director | 66 | 703.55万美元 | 662.79 | 2026-05-13 |
| Jody A. Markopoulos | 女 | Independent Director | 54 | 21.65万美元 | 7.41 | 2026-05-13 |
| Lawrence D. Kingsley | 男 | Independent Director | 63 | 未披露 | 未持股 | 2026-05-13 |
| Sheila Rege | 女 | Independent Director | 60 | 21.65万美元 | 4.25 | 2026-05-13 |
| Steven W. Etzel | 男 | Independent Director | 65 | 未披露 | 未持股 | 2026-05-13 |
| John W. Kuo | 男 | Independent Director | 62 | 未披露 | 未持股 | 2026-05-13 |
| Robert A. Cascella | 男 | Independent Director | 71 | 23.15万美元 | 5.34 | 2026-05-13 |
| John W. Kuo | 男 | Independent Director | 63 | 22.90万美元 | 7.27 | 2026-05-13 |
| Lawrence D. Kingsley | 男 | Independent Director | 63 | 21.65万美元 | 357.20 | 2026-05-13 |
| Steven W. Etzel | 男 | Independent Director | 66 | 23.65万美元 | 8.01 | 2026-05-13 |
高管介绍
注：高管持股数取自最新公司公告
| 姓名 | 性别 | 职位 | 年龄 | 薪酬 | 持股数(万股) | 截止日期 |
|---|---|---|---|---|---|---|
| Thomas D. Logan | 男 | Chairman of the Board,Chief Executive Officer and Director | 66 | 703.55万美元 | 662.79 | 2026-05-13 |
| Emmanuelle Lee | 女 | Chief Compliance Officer and Chief Legal Officer | -- | 110.03万美元 | 40.55 | 2026-05-13 |
| Loic Eloy | 男 | Group President, Nuclear & Safety | -- | 168.47万美元 | 10.67 | 2026-05-13 |
| Brian Schopfer | 男 | Chief Financial Officer and Group President, Medical | -- | 278.99万美元 | 170.05 | 2026-05-13 |
| Alison Ulrich | 女 | Chief Human Resources Officer | -- | 84.61万美元 | 2.42 | 2026-05-13 |
董事简历
中英对照 | 中文 | 英文- Kenneth C. Bockhorst
-
Kenneth C. Bockhorst，2017年10月加入Badger Meter，担任首席运营官，2018年4月晋升为总裁，2019年晋升为首席执行官，2020年晋升为董事会主席。在加入Badger Meter之前，他曾在Actuant Corporation（一家多元化工业公司；现名为Enerpac Tool集团）服务六年，在IDEX和Eaton担任产品管理和运营领导职务，担任更早的职业生涯。
Kenneth C. Bockhorst joined Badger Meter as Chief Operating Officer in October 2017 and was promoted to President in April 2018, Chief Executive Officer in 2019 and Chairman of the Board in 2020. Prior to Badger Meter, he served six years at Actuant Corporation (a diversified indtrial company; now named Enerpac Tool Group) with earlier career roles in product management and operational leadership at IDEX and Eaton. Mr. Bockhorst is a director of Mirion Technologies, Inc. - Kenneth C. Bockhorst，2017年10月加入Badger Meter，担任首席运营官，2018年4月晋升为总裁，2019年晋升为首席执行官，2020年晋升为董事会主席。在加入Badger Meter之前，他曾在Actuant Corporation（一家多元化工业公司；现名为Enerpac Tool集团）服务六年，在IDEX和Eaton担任产品管理和运营领导职务，担任更早的职业生涯。
- Kenneth C. Bockhorst joined Badger Meter as Chief Operating Officer in October 2017 and was promoted to President in April 2018, Chief Executive Officer in 2019 and Chairman of the Board in 2020. Prior to Badger Meter, he served six years at Actuant Corporation (a diversified indtrial company; now named Enerpac Tool Group) with earlier career roles in product management and operational leadership at IDEX and Eaton. Mr. Bockhorst is a director of Mirion Technologies, Inc.
- Kenneth C. Bockhorst
-
Kenneth C. Bockhorst目前担任Badger Meter, Inc.的董事长、总裁兼首席执行官，该公司是一家提供行业领先的智能水务解决方案的全球供应商，该解决方案可在广泛的客户应用中优化运营并提高可持续发展能力。Bockhorst先生于2017年10月加入Badger Meter，担任首席运营官，2018年4月晋升为总裁，2019年晋升为首席执行官，2020年晋升为董事会主席。在加入Badger Meter之前，他曾在多元化工业公司Actuant Corporation（现名为Enerpac Tool集团）任职六年，最后担任能源部门执行副总裁。在加入Actuant之前，他曾在IDEX和伊顿担任产品管理和运营领导职务。Bockhorst先生获得了威斯康星大学麦迪逊分校的工商管理硕士学位和玛丽安大学的运营管理、市场营销和人力资源学士学位。
Kenneth C. Bockhorst currently serves as the Chairman, President and Chief Executive Officer of Badger Meter, Inc., a global provider of industry leading smart water solutions that optimize operations and enhance sustainability across a wide range of customer applications. Mr. Bockhorst joined Badger Meter in October 2017 as Chief Operating Officer, was promoted to President in April 2018, Chief Executive Officer in 2019 and Chairman of the Board in 2020. Prior to Badger Meter, he served six years at Actuant Corporation, a diversified industrial company (now named Enerpac Tool Group), last as Executive Vice President of the Energy segment. Prior to Actuant, he held product management and operational leadership roles at IDEX and Eaton. Mr. Bockhorst received an M.B.A. from the University of Wisconsin Madison and a B.A. from Marian University in Operations Management, Marketing and Human Resources. - Kenneth C. Bockhorst目前担任Badger Meter, Inc.的董事长、总裁兼首席执行官，该公司是一家提供行业领先的智能水务解决方案的全球供应商，该解决方案可在广泛的客户应用中优化运营并提高可持续发展能力。Bockhorst先生于2017年10月加入Badger Meter，担任首席运营官，2018年4月晋升为总裁，2019年晋升为首席执行官，2020年晋升为董事会主席。在加入Badger Meter之前，他曾在多元化工业公司Actuant Corporation（现名为Enerpac Tool集团）任职六年，最后担任能源部门执行副总裁。在加入Actuant之前，他曾在IDEX和伊顿担任产品管理和运营领导职务。Bockhorst先生获得了威斯康星大学麦迪逊分校的工商管理硕士学位和玛丽安大学的运营管理、市场营销和人力资源学士学位。
- Kenneth C. Bockhorst currently serves as the Chairman, President and Chief Executive Officer of Badger Meter, Inc., a global provider of industry leading smart water solutions that optimize operations and enhance sustainability across a wide range of customer applications. Mr. Bockhorst joined Badger Meter in October 2017 as Chief Operating Officer, was promoted to President in April 2018, Chief Executive Officer in 2019 and Chairman of the Board in 2020. Prior to Badger Meter, he served six years at Actuant Corporation, a diversified industrial company (now named Enerpac Tool Group), last as Executive Vice President of the Energy segment. Prior to Actuant, he held product management and operational leadership roles at IDEX and Eaton. Mr. Bockhorst received an M.B.A. from the University of Wisconsin Madison and a B.A. from Marian University in Operations Management, Marketing and Human Resources.
- Robert A. Cascella
-
Robert A. Cascella从Royal Philips（一家荷兰上市医疗保健公司）的战略业务发展负责人职位上退休，该公司自2021年12月31日起生效。他自2020年5月起担任这一职务。2015年4月至2020年4月，任飞利浦诊疗和精准诊断业务执行副总裁兼首席业务负责人（CEO）。他还在2016年1月至2021年4月期间担任菲利普的执行委员会成员。在加入飞利浦之前，Cascella先生曾于2003年2月至2013年12月在公共医疗设备和诊断公司Hologic, Inc.任职，担任总裁和后来的首席执行官。他还曾在CFG Capital、NeoVision Corporation和Fischer Imaging Corporation担任高级领导职务。Cascella先生自2022年6月起担任Koru Medical Systems董事会成员，自2021年4月起担任Neuronetics公司董事会主席，自2020年9月起担任Metabolon公司董事会成员，自2019年4月起担任Celestica公司董事会成员，并自2021年7月起担任薪酬委员会主席。Cascella先生获得了费尔菲尔德大学会计学学士学位。
Robert A. Cascella retired from the position of Strategic Business Development Leader for Royal Philips, a public Dutch healthcare company effective as of December 31, 2021. He had held this position since May 2020. From April 2015 to April 2020, he served as Executive Vice President and Chief Business Leader (CEO) of Philips' Diagnosis and Treatment and Precision Diagnosis businesses. He also served on Philip's Executive Committee from January 2016 to April 2021. Prior to Philips, Mr. Cascella served at Hologic, Inc., a public medical device and diagnostics company, from February 2003 to December 2013 as its president and later CEO. He has also held senior leadership positions at CFG Capital, NeoVision Corporation and Fischer Imaging Corporation. Mr. Cascella has served on the board of Koru Medical Systems since June 2022, as the chair of the board of Neuronetics, Inc. since April 2021, on the board of Metabolon, Inc. since September 2020 and on the board of Celestica Inc. since April 2019, where he has also served as chair of the Compensation Committee since July 2021. Mr. Cascella received a B.A. in accounting from Fairfield University. - Robert A. Cascella从Royal Philips（一家荷兰上市医疗保健公司）的战略业务发展负责人职位上退休，该公司自2021年12月31日起生效。他自2020年5月起担任这一职务。2015年4月至2020年4月，任飞利浦诊疗和精准诊断业务执行副总裁兼首席业务负责人（CEO）。他还在2016年1月至2021年4月期间担任菲利普的执行委员会成员。在加入飞利浦之前，Cascella先生曾于2003年2月至2013年12月在公共医疗设备和诊断公司Hologic, Inc.任职，担任总裁和后来的首席执行官。他还曾在CFG Capital、NeoVision Corporation和Fischer Imaging Corporation担任高级领导职务。Cascella先生自2022年6月起担任Koru Medical Systems董事会成员，自2021年4月起担任Neuronetics公司董事会主席，自2020年9月起担任Metabolon公司董事会成员，自2019年4月起担任Celestica公司董事会成员，并自2021年7月起担任薪酬委员会主席。Cascella先生获得了费尔菲尔德大学会计学学士学位。
- Robert A. Cascella retired from the position of Strategic Business Development Leader for Royal Philips, a public Dutch healthcare company effective as of December 31, 2021. He had held this position since May 2020. From April 2015 to April 2020, he served as Executive Vice President and Chief Business Leader (CEO) of Philips' Diagnosis and Treatment and Precision Diagnosis businesses. He also served on Philip's Executive Committee from January 2016 to April 2021. Prior to Philips, Mr. Cascella served at Hologic, Inc., a public medical device and diagnostics company, from February 2003 to December 2013 as its president and later CEO. He has also held senior leadership positions at CFG Capital, NeoVision Corporation and Fischer Imaging Corporation. Mr. Cascella has served on the board of Koru Medical Systems since June 2022, as the chair of the board of Neuronetics, Inc. since April 2021, on the board of Metabolon, Inc. since September 2020 and on the board of Celestica Inc. since April 2019, where he has also served as chair of the Compensation Committee since July 2021. Mr. Cascella received a B.A. in accounting from Fairfield University.
- Thomas D. Logan
-
Thomas D. Logan是Mirion的创始人，自2005年起担任其首席执行官。他自2005年起担任Mirion董事会成员，自2025年2月起担任董事会主席。在加入Mirion之前，Logan先生曾于2004年至2005年担任辐射剂量测定提供商Global Dosimetry Solutions的首席执行官。在2004年之前，Logan先生曾担任BAF Energy总裁、E M Solutions和BVP，Inc.的首席财务官，在此之前，曾在雪佛龙担任多个财务领导职务。Logan先生拥有30多年的能源行业经验，以及在合同制造和消费品行业内的丰富经验。洛根先生获得了康奈尔大学的工商管理硕士学位和学士学位。
Thomas D. Logan is the Founder of Mirion, and has served as its Chief Executive Officer since 2005. He has served as a member of Mirion's Board of Directors since 2005 and as the Chairman of the Board since February 2025. Prior to joining Mirion, Mr. Logan served as Chief Executive Officer for Global Dosimetry Solutions, a radiation dosimetry provider, from 2004 to 2005. Prior to 2004, Mr. Logan served as President of BAF Energy, CFO of E M Solutions and of BVP, Inc. and prior to that, held various finance leadership positions at Chevron. Mr. Logan has more than 30 years of energy industry experience, as well as extensive experience within the contract manufacturing and consumer products industries. Mr. Logan received a M.B.A. and a B.S. from Cornell University. - Thomas D. Logan是Mirion的创始人，自2005年起担任其首席执行官。他自2005年起担任Mirion董事会成员，自2025年2月起担任董事会主席。在加入Mirion之前，Logan先生曾于2004年至2005年担任辐射剂量测定提供商Global Dosimetry Solutions的首席执行官。在2004年之前，Logan先生曾担任BAF Energy总裁、E M Solutions和BVP，Inc.的首席财务官，在此之前，曾在雪佛龙担任多个财务领导职务。Logan先生拥有30多年的能源行业经验，以及在合同制造和消费品行业内的丰富经验。洛根先生获得了康奈尔大学的工商管理硕士学位和学士学位。
- Thomas D. Logan is the Founder of Mirion, and has served as its Chief Executive Officer since 2005. He has served as a member of Mirion's Board of Directors since 2005 and as the Chairman of the Board since February 2025. Prior to joining Mirion, Mr. Logan served as Chief Executive Officer for Global Dosimetry Solutions, a radiation dosimetry provider, from 2004 to 2005. Prior to 2004, Mr. Logan served as President of BAF Energy, CFO of E M Solutions and of BVP, Inc. and prior to that, held various finance leadership positions at Chevron. Mr. Logan has more than 30 years of energy industry experience, as well as extensive experience within the contract manufacturing and consumer products industries. Mr. Logan received a M.B.A. and a B.S. from Cornell University.
- Jody A. Markopoulos
-
Jody A. Markopoulos目前是一名独立顾问。此前，Markopoulos女士于2021年3月至2021年11月担任Eos Energy Enterprises, Inc.的首席运营官，该公司是一家为电力公用事业行业提供电池存储解决方案的供应商。此前，她曾在通用电气和Baker Hughes担任多个运营领导职务，任职26年。她曾于2017年至2018年在新合并的上市公司成立之初的GE公司Baker Hughes担任首席供应链官，负责制造和供应链运营，随后于2018年至2020年担任首席过渡官，负责执行从GE有序过渡的工作。在通用电气，她于2015年至2017年担任GE Oil & Gas首席运营官，2011年至2014年担任工业自动化、控制和软件公司GE Intelligent Platforms总裁兼首席执行官，2005年至2011年担任GE Energy采购副总裁。Markopoulos女士自2022年9月起担任White Cap的董事会董事，并且是其审计和薪酬委员会的成员。Markopoulos女士获得克拉克森大学跨学科工程和管理学士学位。
Jody A. Markopoulos is currently an independent consultant. Previously, Ms. Markopoulos served as the Chief Operating Officer of Eos Energy Enterprises, Inc., a provider of battery storage solutions for the electric utility industry from March 2021 to November 2021. Previously, she spent 26 years in multiple operating leadership positions at General Electric and Baker Hughes. She served as Chief Supply Chain Officer at Baker Hughes, a GE company at the inception of the newly merged public company, responsible for manufacturing and supply chain operations, from 2017 to 2018, and then as Chief Transition Officer from 2018 to 2020, responsible for executing the orderly transition from GE. At General Electric, she served as Chief Operations Officer at GE Oil & Gas from 2015 to 2017, President and CEO of GE Intelligent Platforms, an industrial automation, controls and software company from 2011 to 2014, and as Vice President of Sourcing at GE Energy from 2005 to 2011. Ms. Markopoulos has served as a board director at White Cap since September 2022 and is a member of their audit and compensation committees. Ms. Markopoulos received a B.S. in Interdisciplinary Engineering and Management from Clarkson University. - Jody A. Markopoulos目前是一名独立顾问。此前，Markopoulos女士于2021年3月至2021年11月担任Eos Energy Enterprises, Inc.的首席运营官，该公司是一家为电力公用事业行业提供电池存储解决方案的供应商。此前，她曾在通用电气和Baker Hughes担任多个运营领导职务，任职26年。她曾于2017年至2018年在新合并的上市公司成立之初的GE公司Baker Hughes担任首席供应链官，负责制造和供应链运营，随后于2018年至2020年担任首席过渡官，负责执行从GE有序过渡的工作。在通用电气，她于2015年至2017年担任GE Oil & Gas首席运营官，2011年至2014年担任工业自动化、控制和软件公司GE Intelligent Platforms总裁兼首席执行官，2005年至2011年担任GE Energy采购副总裁。Markopoulos女士自2022年9月起担任White Cap的董事会董事，并且是其审计和薪酬委员会的成员。Markopoulos女士获得克拉克森大学跨学科工程和管理学士学位。
- Jody A. Markopoulos is currently an independent consultant. Previously, Ms. Markopoulos served as the Chief Operating Officer of Eos Energy Enterprises, Inc., a provider of battery storage solutions for the electric utility industry from March 2021 to November 2021. Previously, she spent 26 years in multiple operating leadership positions at General Electric and Baker Hughes. She served as Chief Supply Chain Officer at Baker Hughes, a GE company at the inception of the newly merged public company, responsible for manufacturing and supply chain operations, from 2017 to 2018, and then as Chief Transition Officer from 2018 to 2020, responsible for executing the orderly transition from GE. At General Electric, she served as Chief Operations Officer at GE Oil & Gas from 2015 to 2017, President and CEO of GE Intelligent Platforms, an industrial automation, controls and software company from 2011 to 2014, and as Vice President of Sourcing at GE Energy from 2005 to 2011. Ms. Markopoulos has served as a board director at White Cap since September 2022 and is a member of their audit and compensation committees. Ms. Markopoulos received a B.S. in Interdisciplinary Engineering and Management from Clarkson University.
- Lawrence D. Kingsley
-
Lawrence D. Kingsley目前自2019年11月起担任上市公司爱德士，Inc.的独立非执行董事会主席，自2016年5月起担任投资公司Berkshire Partners LLC的顾问董事。Kingsley先生目前还担任上市公司Polaris Industries Inc.的董事，自2016年1月起担任该公司的董事，自2019年9月起担任私营公司Consolidated Precision Products Corporations的董事，自2023年9月起担任私营公司Harvey Performance Company的董事。在加入爱德士公司之前，Kingsley先生于2013年10月至2015年8月期间担任颇尔公司董事长，并于2011年10月至2015年8月期间担任颇尔公司总裁兼首席执行官，直至丹纳赫公司是一家上市公司，于2015年8月收购颇尔。在任职于颇尔之前，Kingsley先生曾于2005年3月至2011年8月担任IDEX公司的首席执行官兼总裁，该公司是一家专门开发、设计和制造流体和计量技术、健康和科学技术以及消防、安全和其他多样化产品的上市公司，并于2004年8月至2005年3月担任IDEX公司的首席运营官兼总裁。Kingsley先生此前曾于2011年10月至2015年8月担任颇尔的董事，于2007年至2012年担任Cooper Industries PLC（前身为Cooper Industries Ltd.）一家上市公司的董事，并于2005年至2011年担任IDEX公司的董事。2013年至2021年，他还担任罗克韦尔自动化公司的董事。Kingsley先生曾在丹纳赫公司担任过越来越重要的各个职位，包括2004年3月至2004年8月的公司副总裁和集团执行官、2002年4月至2004年7月的工业控制集团总裁以及2001年1月至2002年3月的特殊目的系统公司Motion集团总裁。金斯利先生此前还曾在Kollmorgen Corporation和Weidmuller Incorporated担任管理职务，责任越来越大。Kingsley先生在克拉克森大学获得工业工程和管理本科学位，并在威廉和玛丽学院获得工商管理硕士学位。
Lawrence D. Kingsley currently serves as the independent Non Executive Board Chair of IDEXX Laboratories, Inc., a public company, since November 2019 and as an Advisory Director to Berkshire Partners LLC, an investment company, since May 2016. Mr. Kingsley also currently serves as a Director of Polaris Industries Inc., a public company, since January 2016, Consolidated Precision Products Corporations, a private company, since September 2019 and Harvey Performance Company, a private company, since September 2023. Prior to joining IDEXX Laboratories, Inc., Mr. Kingsley served as Chairman of Pall Corporation from October 2013 to August 2015 and as President and Chief Executive Officer of Pall Corporation from October 2011 to August 2015 until Danaher Corporation, a public company, acquired Pall Corporation in August 2015. Before his experience at Pall Corporation, Mr. Kingsley served as the Chief Executive Officer and President of IDEX Corporation, a public company specializing in the development, design and manufacture of fluid and metering technologies, health and science technologies and fire, safety and other diversified products, from March 2005 to August 2011, and the Chief Operating Officer of IDEX Corporation from August 2004 to March 2005. Mr. Kingsley previously served as a Director of Pall Corporation from October 2011 to August 2015, Cooper Industries plc (formerly Cooper Industries Ltd.), a public company, from 2007 to 2012 and IDEX Corporation from 2005 to 2011. He was also a director of Rockwell Automation, Inc. from 2013 to 2021. Mr. Kingsley served in various positions of increasing responsibility at Danaher Corporation, including Corporate Vice President and Group Executive from March 2004 to August 2004, President of Industrial Controls Group from April 2002 to July 2004 and President of Motion Group, Special Purpose Systems from January 2001 to March 2002. Mr. Kingsley also previously held management positions of increasing responsibility at Kollmorgen Corporation and Weidmuller Incorporated. Mr. Kingsley received an undergraduate degree in Industrial Engineering and Management from Clarkson University and an M.B.A. from the College of William and Mary. - Lawrence D. Kingsley目前自2019年11月起担任上市公司爱德士，Inc.的独立非执行董事会主席，自2016年5月起担任投资公司Berkshire Partners LLC的顾问董事。Kingsley先生目前还担任上市公司Polaris Industries Inc.的董事，自2016年1月起担任该公司的董事，自2019年9月起担任私营公司Consolidated Precision Products Corporations的董事，自2023年9月起担任私营公司Harvey Performance Company的董事。在加入爱德士公司之前，Kingsley先生于2013年10月至2015年8月期间担任颇尔公司董事长，并于2011年10月至2015年8月期间担任颇尔公司总裁兼首席执行官，直至丹纳赫公司是一家上市公司，于2015年8月收购颇尔。在任职于颇尔之前，Kingsley先生曾于2005年3月至2011年8月担任IDEX公司的首席执行官兼总裁，该公司是一家专门开发、设计和制造流体和计量技术、健康和科学技术以及消防、安全和其他多样化产品的上市公司，并于2004年8月至2005年3月担任IDEX公司的首席运营官兼总裁。Kingsley先生此前曾于2011年10月至2015年8月担任颇尔的董事，于2007年至2012年担任Cooper Industries PLC（前身为Cooper Industries Ltd.）一家上市公司的董事，并于2005年至2011年担任IDEX公司的董事。2013年至2021年，他还担任罗克韦尔自动化公司的董事。Kingsley先生曾在丹纳赫公司担任过越来越重要的各个职位，包括2004年3月至2004年8月的公司副总裁和集团执行官、2002年4月至2004年7月的工业控制集团总裁以及2001年1月至2002年3月的特殊目的系统公司Motion集团总裁。金斯利先生此前还曾在Kollmorgen Corporation和Weidmuller Incorporated担任管理职务，责任越来越大。Kingsley先生在克拉克森大学获得工业工程和管理本科学位，并在威廉和玛丽学院获得工商管理硕士学位。
- Lawrence D. Kingsley currently serves as the independent Non Executive Board Chair of IDEXX Laboratories, Inc., a public company, since November 2019 and as an Advisory Director to Berkshire Partners LLC, an investment company, since May 2016. Mr. Kingsley also currently serves as a Director of Polaris Industries Inc., a public company, since January 2016, Consolidated Precision Products Corporations, a private company, since September 2019 and Harvey Performance Company, a private company, since September 2023. Prior to joining IDEXX Laboratories, Inc., Mr. Kingsley served as Chairman of Pall Corporation from October 2013 to August 2015 and as President and Chief Executive Officer of Pall Corporation from October 2011 to August 2015 until Danaher Corporation, a public company, acquired Pall Corporation in August 2015. Before his experience at Pall Corporation, Mr. Kingsley served as the Chief Executive Officer and President of IDEX Corporation, a public company specializing in the development, design and manufacture of fluid and metering technologies, health and science technologies and fire, safety and other diversified products, from March 2005 to August 2011, and the Chief Operating Officer of IDEX Corporation from August 2004 to March 2005. Mr. Kingsley previously served as a Director of Pall Corporation from October 2011 to August 2015, Cooper Industries plc (formerly Cooper Industries Ltd.), a public company, from 2007 to 2012 and IDEX Corporation from 2005 to 2011. He was also a director of Rockwell Automation, Inc. from 2013 to 2021. Mr. Kingsley served in various positions of increasing responsibility at Danaher Corporation, including Corporate Vice President and Group Executive from March 2004 to August 2004, President of Industrial Controls Group from April 2002 to July 2004 and President of Motion Group, Special Purpose Systems from January 2001 to March 2002. Mr. Kingsley also previously held management positions of increasing responsibility at Kollmorgen Corporation and Weidmuller Incorporated. Mr. Kingsley received an undergraduate degree in Industrial Engineering and Management from Clarkson University and an M.B.A. from the College of William and Mary.
- Sheila Rege
-
Sheila Rege是一名获得董事会认证的放射肿瘤学家，也是Northwest Cancer Clinic的创始人和前首席执行官，该公司是一家于2012年开业的放射肿瘤学和核医学服务提供商。雷格博士目前担任美国医学协会董事会成员，并在美国放射肿瘤学会（ASTO）放射药物治疗委员会任职。从2007年到2019年，雷格博士担任医师保险的董事会成员，担任提名委员会主席以及薪酬、执行和CEO继任委员会成员。Rege博士，华盛顿州立大学（WSUU）教职员工，获得的表彰包括美国放射肿瘤学会（ACRO）2023年金奖、2021年美国医学协会灵感奖、私营公司董事会会议室2022年“值得关注的董事”、ACRO 2022年Sucha Asbell导师奖，并被美国消费者研究委员会（Consumer Research Council of America）认定为2012年“顶级肿瘤学家”。Rege博士获得了美国公司董事协会网络风险监督项目的CERT证书。Rege博士在加州大学伯克利分校获得学士学位，在加州大学洛杉矶分校获得医学博士学位，在坎伯兰兹大学获得金融硕士学位。
Sheila Rege is a board certified radiation oncologist and the Founder and former Chief Executive Officer of Northwest Cancer Clinic, a provider of radiation oncology and nuclear medicine services, which opened in 2012. Dr. Rege currently sits on the American Medical Association Board of Trustees and serves on the American Society for Radiation Oncology (ASTRO) Radiopharmaceutical Therapy Committee. From 2007 to 2019, Dr. Rege sat on the Board of Directors of Physicians Insurance, serving as the Chair of the Nominating Committee and a member of the Compensation, Executive and CEO Succession Committees. Dr. Rege, a Washington State University (WSU) faculty member, has received recognitions including the American College of Radiation Oncology (ACRO) 2023 Gold Medal Award, American Medical Association Inspiration Award in 2021, the Private Company Boardroom 2022 "Directors to Watch," the ACRO 2022 Sucha Asbell Mentorship Award, and has been recognized as a "Top Oncologist" by the Consumer Research Council of America in 2012. Dr. Rege earned a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors. Dr. Rege received her B.A. from the University of California, Berkeley, her M.D. from the University of California, Los Angeles, and her M.S. in Finance from the University of the Cumberlands. - Sheila Rege是一名获得董事会认证的放射肿瘤学家，也是Northwest Cancer Clinic的创始人和前首席执行官，该公司是一家于2012年开业的放射肿瘤学和核医学服务提供商。雷格博士目前担任美国医学协会董事会成员，并在美国放射肿瘤学会（ASTO）放射药物治疗委员会任职。从2007年到2019年，雷格博士担任医师保险的董事会成员，担任提名委员会主席以及薪酬、执行和CEO继任委员会成员。Rege博士，华盛顿州立大学（WSUU）教职员工，获得的表彰包括美国放射肿瘤学会（ACRO）2023年金奖、2021年美国医学协会灵感奖、私营公司董事会会议室2022年“值得关注的董事”、ACRO 2022年Sucha Asbell导师奖，并被美国消费者研究委员会（Consumer Research Council of America）认定为2012年“顶级肿瘤学家”。Rege博士获得了美国公司董事协会网络风险监督项目的CERT证书。Rege博士在加州大学伯克利分校获得学士学位，在加州大学洛杉矶分校获得医学博士学位，在坎伯兰兹大学获得金融硕士学位。
- Sheila Rege is a board certified radiation oncologist and the Founder and former Chief Executive Officer of Northwest Cancer Clinic, a provider of radiation oncology and nuclear medicine services, which opened in 2012. Dr. Rege currently sits on the American Medical Association Board of Trustees and serves on the American Society for Radiation Oncology (ASTRO) Radiopharmaceutical Therapy Committee. From 2007 to 2019, Dr. Rege sat on the Board of Directors of Physicians Insurance, serving as the Chair of the Nominating Committee and a member of the Compensation, Executive and CEO Succession Committees. Dr. Rege, a Washington State University (WSU) faculty member, has received recognitions including the American College of Radiation Oncology (ACRO) 2023 Gold Medal Award, American Medical Association Inspiration Award in 2021, the Private Company Boardroom 2022 "Directors to Watch," the ACRO 2022 Sucha Asbell Mentorship Award, and has been recognized as a "Top Oncologist" by the Consumer Research Council of America in 2012. Dr. Rege earned a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors. Dr. Rege received her B.A. from the University of California, Berkeley, her M.D. from the University of California, Los Angeles, and her M.S. in Finance from the University of the Cumberlands.
- Steven W. Etzel
-
Steven W. Etzel于2020年11月至2021年2月期间，在专注于工业自动化和信息化的罗克韦尔自动化公司公司担任高级副总裁兼首席财务官，随后担任罗克韦尔财务高级副总裁，直至2021年4月退休。Etzel先生于1989年加入罗克韦尔，曾担任多个职位，包括2007年至2020年的副总裁兼财务主管，以及2020年10月至2020年11月的财务副总裁。Etzel先生获得了宾夕法尼亚西部大学（前身为宾夕法尼亚克拉里昂大学）的工商管理理学学士学位，并获得了美国公司董事协会网络风险监督项目的CERT证书。Etzel先生是CFA包租人。
Steven W. Etzel served as Senior Vice President and Chief Financial Officer of Rockwell Automation, Inc., a company focused on industrial automation and information, from November 2020 to February 2021, and subsequently as Senior Vice President, Finance of Rockwell until his retirement in April 2021. Mr. Etzel joined Rockwell in 1989 and served in various positions, including Vice President and Treasurer from 2007 to 2020 and Vice President, Finance from October 2020 to November 2020. Mr. Etzel received his Bachelor of Science degree in Business Administration from Pennsylvania Western University (formerly known as Clarion University of Pennsylvania) and earned a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors. Mr. Etzel is a CFA charterholder. - Steven W. Etzel于2020年11月至2021年2月期间，在专注于工业自动化和信息化的罗克韦尔自动化公司公司担任高级副总裁兼首席财务官，随后担任罗克韦尔财务高级副总裁，直至2021年4月退休。Etzel先生于1989年加入罗克韦尔，曾担任多个职位，包括2007年至2020年的副总裁兼财务主管，以及2020年10月至2020年11月的财务副总裁。Etzel先生获得了宾夕法尼亚西部大学（前身为宾夕法尼亚克拉里昂大学）的工商管理理学学士学位，并获得了美国公司董事协会网络风险监督项目的CERT证书。Etzel先生是CFA包租人。
- Steven W. Etzel served as Senior Vice President and Chief Financial Officer of Rockwell Automation, Inc., a company focused on industrial automation and information, from November 2020 to February 2021, and subsequently as Senior Vice President, Finance of Rockwell until his retirement in April 2021. Mr. Etzel joined Rockwell in 1989 and served in various positions, including Vice President and Treasurer from 2007 to 2020 and Vice President, Finance from October 2020 to November 2020. Mr. Etzel received his Bachelor of Science degree in Business Administration from Pennsylvania Western University (formerly known as Clarion University of Pennsylvania) and earned a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors. Mr. Etzel is a CFA charterholder.
- John W. Kuo
-
John W. Kuo于2021年9月至2022年10月退休期间担任分子诊断公司Visby Medical的首席法务官，该公司是一家私人控股的公司。此前，他曾于2020年5月至2020年9月担任纽交所上市、财富1000强全球合同药物研发公司Charles River Laboratories的执行副总裁、总法律顾问、首席合规官和公司秘书。在此之前，郭先生于2005年7月至2020年5月担任瓦里安医疗的高级副总裁、总法律顾问和公司秘书，该公司是一家在纽约证券交易所上市的《财富》1000强全球癌症治疗/放射治疗公司。他还曾分别在欧洲和亚洲的能源和高科技行业担任高级外派职务。郭先生在加州大学伯克利分校法学院获得法学博士学位，在康奈尔大学获得生物学与社会学士学位。郭先生获得了美国斯坦福大学商学院AEA/斯坦福执行学院的证书，以及美国公司董事协会网络风险监督项目的CERT证书。
John W. Kuo was the Chief Legal Officer of Visby Medical, a privately held molecular diagnostic company from September 2021 until his retirement in October 2022. Previously, he was the Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Charles River Laboratories, a NYSE listed, Fortune 1000 global contract drug research and development company, from May 2020 to September 2020. Before that, Mr. Kuo was the Senior Vice President, General Counsel and Corporate Secretary of Varian Medical Systems, a NYSE listed, Fortune 1000 global cancer therapy/radiation therapy company, from July 2005 to May 2020. He also previously served in senior expatriate roles in Europe and Asia in the energy and high technology industries, respectively. Mr. Kuo received his J.D. from the University of California, Berkeley School of Law and his B.A. in Biology & Society from Cornell University. Mr. Kuo earned a certificate from the AEA/Stanford Executive Institute, Stanford Graduate School of Business, as well as a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors. - John W. Kuo于2021年9月至2022年10月退休期间担任分子诊断公司Visby Medical的首席法务官，该公司是一家私人控股的公司。此前，他曾于2020年5月至2020年9月担任纽交所上市、财富1000强全球合同药物研发公司Charles River Laboratories的执行副总裁、总法律顾问、首席合规官和公司秘书。在此之前，郭先生于2005年7月至2020年5月担任瓦里安医疗的高级副总裁、总法律顾问和公司秘书，该公司是一家在纽约证券交易所上市的《财富》1000强全球癌症治疗/放射治疗公司。他还曾分别在欧洲和亚洲的能源和高科技行业担任高级外派职务。郭先生在加州大学伯克利分校法学院获得法学博士学位，在康奈尔大学获得生物学与社会学士学位。郭先生获得了美国斯坦福大学商学院AEA/斯坦福执行学院的证书，以及美国公司董事协会网络风险监督项目的CERT证书。
- John W. Kuo was the Chief Legal Officer of Visby Medical, a privately held molecular diagnostic company from September 2021 until his retirement in October 2022. Previously, he was the Executive Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary of Charles River Laboratories, a NYSE listed, Fortune 1000 global contract drug research and development company, from May 2020 to September 2020. Before that, Mr. Kuo was the Senior Vice President, General Counsel and Corporate Secretary of Varian Medical Systems, a NYSE listed, Fortune 1000 global cancer therapy/radiation therapy company, from July 2005 to May 2020. He also previously served in senior expatriate roles in Europe and Asia in the energy and high technology industries, respectively. Mr. Kuo received his J.D. from the University of California, Berkeley School of Law and his B.A. in Biology & Society from Cornell University. Mr. Kuo earned a certificate from the AEA/Stanford Executive Institute, Stanford Graduate School of Business, as well as a CERT Certificate in the Cyber Risk Oversight Program from the National Association of Corporate Directors.
- Robert A. Cascella
-
Robert A. Cascella，现任荷兰皇家飞利浦公司（Royal Philips）执行副总裁兼执行委员会成员，该公司是一家荷兰上市跨国医疗保健公司。他还是飞利浦精密诊断业务的首席执行官兼首席执行官，包括服务于放射学、心脏病学和肿瘤学的业务，以及企业诊断信息学。他于2003年至2013年担任公共医疗器械和诊断公司Hologic, Inc.的总裁兼首席执行官。他还曾在CFG Capital、NeoVision Corporation和Fischer Imaging Corporation担任高级领导职务。Cascella先生于2008年至2013年在Hologic, Inc.董事会任职。他此前还曾在Tegra Medical董事会任职，并担任Dysis Medical和Miranda Medical的董事会主席。他拥有费尔菲尔德大学会计学学士学位。
Robert A. Cascella is a corporate director with more than 30 years of experience in the healthcare industry in a range of senior management positions. He currently serves as a director of Koru Medical Systems Inc., a medical technology company, and Mirion Technologies, Inc., a radiation detection and measurement products and services company, and serves as chair of the board of directors of Neuronetics, Inc., a medical device company. He most recently served as Special Advisor and Strategic Business Development Leader at Royal Philips, a public Dutch multinational healthcare company, during 2021. From 2015 to 2021, he served as Executive Vice President of Royal Philips and Chief Executive Officer of Philips' Diagnosis and Treatment businesses, including businesses serving Radiology, Cardiology and Oncology, as well as Enterprise Diagnostic Informatics. Mr. Cascella has also served on Philips' Executive Committee from 2016 to 2021. Since 2021, he has served on the board of directors of Metabolon Inc., a private company using metabolomics to assist in the discovery of biomarkers. Prior to Philips, Mr. Cascella spent ten years as President and later CEO of Hologic Inc., a public medical device and diagnostic company. He also served on Hologic, Inc.'s board of directors from 2008 to 2013. He has also held senior leadership positions at CFG Capital, NeoVision Corporation and Fisher Imaging Corporation.Mr. Cascella holds a Bachelor's degree in Accounting from Fairfield University and is National Association of Corporate Directors (NACD) Directorship certified. - Robert A. Cascella，现任荷兰皇家飞利浦公司（Royal Philips）执行副总裁兼执行委员会成员，该公司是一家荷兰上市跨国医疗保健公司。他还是飞利浦精密诊断业务的首席执行官兼首席执行官，包括服务于放射学、心脏病学和肿瘤学的业务，以及企业诊断信息学。他于2003年至2013年担任公共医疗器械和诊断公司Hologic, Inc.的总裁兼首席执行官。他还曾在CFG Capital、NeoVision Corporation和Fischer Imaging Corporation担任高级领导职务。Cascella先生于2008年至2013年在Hologic, Inc.董事会任职。他此前还曾在Tegra Medical董事会任职，并担任Dysis Medical和Miranda Medical的董事会主席。他拥有费尔菲尔德大学会计学学士学位。
- Robert A. Cascella is a corporate director with more than 30 years of experience in the healthcare industry in a range of senior management positions. He currently serves as a director of Koru Medical Systems Inc., a medical technology company, and Mirion Technologies, Inc., a radiation detection and measurement products and services company, and serves as chair of the board of directors of Neuronetics, Inc., a medical device company. He most recently served as Special Advisor and Strategic Business Development Leader at Royal Philips, a public Dutch multinational healthcare company, during 2021. From 2015 to 2021, he served as Executive Vice President of Royal Philips and Chief Executive Officer of Philips' Diagnosis and Treatment businesses, including businesses serving Radiology, Cardiology and Oncology, as well as Enterprise Diagnostic Informatics. Mr. Cascella has also served on Philips' Executive Committee from 2016 to 2021. Since 2021, he has served on the board of directors of Metabolon Inc., a private company using metabolomics to assist in the discovery of biomarkers. Prior to Philips, Mr. Cascella spent ten years as President and later CEO of Hologic Inc., a public medical device and diagnostic company. He also served on Hologic, Inc.'s board of directors from 2008 to 2013. He has also held senior leadership positions at CFG Capital, NeoVision Corporation and Fisher Imaging Corporation.Mr. Cascella holds a Bachelor's degree in Accounting from Fairfield University and is National Association of Corporate Directors (NACD) Directorship certified.
- John W. Kuo
-
John W. Kuo于2012年2月被任命为高级副总裁、总法律顾问兼公司秘书。在此之前，自2005年7月至2012年1月担任公司副总裁兼法律总顾问，自2005年2月起担任公司秘书。2003年3月加入公司，担任高级企业法律顾问，2004年3月成为助理总法律顾问。加入公司前，2002年担任宏道公司（电子商务软件提供商）的总顾问和秘书，1997年至2002年在3Com公司（一个网络设备供应商）担任高级法律职务。以前曾在Gray Cary Ware & Freidenrich（现为欧华律师事务所）和Fulbright & Jaworski律师事务所工作。在康奈尔大学获得文学学士学位，在加州大学伯克利分校博尔特厅法学院获得法学博士学位。
John W. Kuo was appointed Senior Vice President, in addition to being General Counsel and Corporate Secretary, in February 2012. Prior to that, he served as Corporate Vice President and General Counsel from July 2005 through January 2012 and as Corporate Secretary since February 2005. Mr. Kuo joined the Company as Senior Corporate Counsel in March 2003 and became Associate General Counsel in March 2004. Prior to joining the Company, Mr. Kuo was General Counsel and Secretary at BroadVision, Inc. an e-commerce software provider and held senior legal positions at 3Com Corporation a networking equipment provider. Mr. Kuo has previously been with the law firms of Gray Cary Ware & Freidenrich (now DLA Piper) and Fulbright & Jaworski. Mr. Kuo holds a B.A. degree from Cornell University and a J.D. degree from Berkeley Law at the University of California at Berkeley. - John W. Kuo于2012年2月被任命为高级副总裁、总法律顾问兼公司秘书。在此之前，自2005年7月至2012年1月担任公司副总裁兼法律总顾问，自2005年2月起担任公司秘书。2003年3月加入公司，担任高级企业法律顾问，2004年3月成为助理总法律顾问。加入公司前，2002年担任宏道公司（电子商务软件提供商）的总顾问和秘书，1997年至2002年在3Com公司（一个网络设备供应商）担任高级法律职务。以前曾在Gray Cary Ware & Freidenrich（现为欧华律师事务所）和Fulbright & Jaworski律师事务所工作。在康奈尔大学获得文学学士学位，在加州大学伯克利分校博尔特厅法学院获得法学博士学位。
- John W. Kuo was appointed Senior Vice President, in addition to being General Counsel and Corporate Secretary, in February 2012. Prior to that, he served as Corporate Vice President and General Counsel from July 2005 through January 2012 and as Corporate Secretary since February 2005. Mr. Kuo joined the Company as Senior Corporate Counsel in March 2003 and became Associate General Counsel in March 2004. Prior to joining the Company, Mr. Kuo was General Counsel and Secretary at BroadVision, Inc. an e-commerce software provider and held senior legal positions at 3Com Corporation a networking equipment provider. Mr. Kuo has previously been with the law firms of Gray Cary Ware & Freidenrich (now DLA Piper) and Fulbright & Jaworski. Mr. Kuo holds a B.A. degree from Cornell University and a J.D. degree from Berkeley Law at the University of California at Berkeley.
- Lawrence D. Kingsley
-
Lawrence D. Kingsley拥有创新和技术专长以及全球、战略和并购，以及在消费/制造行业的执行领导经验，这些经验是通过在颇尔和IDEX Corporation担任高级领导职务而获得的，这两家公司都是高技术、高增长的跨国上市公司。全球过滤、分离和净化产品供应商颇尔：董事长兼首席执行官（2013 – 2015）；首席执行官兼总裁（2011 – 2013）。IDEX公司董事长、总裁兼首席执行官，该公司是流体和计量技术以及健康和科学技术的开发商、设计者和制造商（2005 – 2011）；曾在丹纳赫公司、Kollmorgen公司和Weidmuller Incorporated担任越来越重要的管理职务；私募股权投资公司Berkshire Partners的顾问董事（自2016年5月起）；在Berkshire Partners投资组合公司Consolidated Precision Products和Harvey Performance的董事会任职；在董事会任职，并担任千岛土地信托基金总裁。
Lawrence D. Kingsley,has innovation and technology expertise and global, strategy and M&A, and executive leadership experience in the consumer/manufacturing industry gained through his senior leadership roles with Pall Corporation and IDEX Corporation, both high-technology, high-growth multinational public companies. Pall Corporation, a global supplier of filtration, separations and purification products: Chairman and Chief Executive Officer (2013 – 2015); Chief Executive Officer and President (2011 – 2013). Chairman, President and CEO, IDEX Corporation, a developer, designer and manufacturer of fluid and metering technologies and health and science technologies (2005 – 2011); Held management positions of increasing responsibility with Danaher Corporation, Kollmorgen Corporation and Weidmuller Incorporated; Advisory Director to Berkshire Partners, private equity investment firm (since May 2016); Serves on the boards of Consolidated Precision Products and Harvey Performance, both Berkshire Partners portfolio companies; Serves on the board and is President of the Thousand Islands Land Trust. - Lawrence D. Kingsley拥有创新和技术专长以及全球、战略和并购，以及在消费/制造行业的执行领导经验，这些经验是通过在颇尔和IDEX Corporation担任高级领导职务而获得的，这两家公司都是高技术、高增长的跨国上市公司。全球过滤、分离和净化产品供应商颇尔：董事长兼首席执行官（2013 – 2015）；首席执行官兼总裁（2011 – 2013）。IDEX公司董事长、总裁兼首席执行官，该公司是流体和计量技术以及健康和科学技术的开发商、设计者和制造商（2005 – 2011）；曾在丹纳赫公司、Kollmorgen公司和Weidmuller Incorporated担任越来越重要的管理职务；私募股权投资公司Berkshire Partners的顾问董事（自2016年5月起）；在Berkshire Partners投资组合公司Consolidated Precision Products和Harvey Performance的董事会任职；在董事会任职，并担任千岛土地信托基金总裁。
- Lawrence D. Kingsley,has innovation and technology expertise and global, strategy and M&A, and executive leadership experience in the consumer/manufacturing industry gained through his senior leadership roles with Pall Corporation and IDEX Corporation, both high-technology, high-growth multinational public companies. Pall Corporation, a global supplier of filtration, separations and purification products: Chairman and Chief Executive Officer (2013 – 2015); Chief Executive Officer and President (2011 – 2013). Chairman, President and CEO, IDEX Corporation, a developer, designer and manufacturer of fluid and metering technologies and health and science technologies (2005 – 2011); Held management positions of increasing responsibility with Danaher Corporation, Kollmorgen Corporation and Weidmuller Incorporated; Advisory Director to Berkshire Partners, private equity investment firm (since May 2016); Serves on the boards of Consolidated Precision Products and Harvey Performance, both Berkshire Partners portfolio companies; Serves on the board and is President of the Thousand Islands Land Trust.
- Steven W. Etzel
-
Steven W. Etzel，自2007年11起任副总裁兼财务总监，之前任助理财务总监。
Steven W. Etzel, Vice President, Finance since October 1 2020; previously Vice President and Treasurer. - Steven W. Etzel，自2007年11起任副总裁兼财务总监，之前任助理财务总监。
- Steven W. Etzel, Vice President, Finance since October 1 2020; previously Vice President and Treasurer.
高管简历
中英对照 | 中文 | 英文- Thomas D. Logan
Thomas D. Logan是Mirion的创始人，自2005年起担任其首席执行官。他自2005年起担任Mirion董事会成员，自2025年2月起担任董事会主席。在加入Mirion之前，Logan先生曾于2004年至2005年担任辐射剂量测定提供商Global Dosimetry Solutions的首席执行官。在2004年之前，Logan先生曾担任BAF Energy总裁、E M Solutions和BVP，Inc.的首席财务官，在此之前，曾在雪佛龙担任多个财务领导职务。Logan先生拥有30多年的能源行业经验，以及在合同制造和消费品行业内的丰富经验。洛根先生获得了康奈尔大学的工商管理硕士学位和学士学位。
Thomas D. Logan is the Founder of Mirion, and has served as its Chief Executive Officer since 2005. He has served as a member of Mirion's Board of Directors since 2005 and as the Chairman of the Board since February 2025. Prior to joining Mirion, Mr. Logan served as Chief Executive Officer for Global Dosimetry Solutions, a radiation dosimetry provider, from 2004 to 2005. Prior to 2004, Mr. Logan served as President of BAF Energy, CFO of E M Solutions and of BVP, Inc. and prior to that, held various finance leadership positions at Chevron. Mr. Logan has more than 30 years of energy industry experience, as well as extensive experience within the contract manufacturing and consumer products industries. Mr. Logan received a M.B.A. and a B.S. from Cornell University.- Thomas D. Logan是Mirion的创始人，自2005年起担任其首席执行官。他自2005年起担任Mirion董事会成员，自2025年2月起担任董事会主席。在加入Mirion之前，Logan先生曾于2004年至2005年担任辐射剂量测定提供商Global Dosimetry Solutions的首席执行官。在2004年之前，Logan先生曾担任BAF Energy总裁、E M Solutions和BVP，Inc.的首席财务官，在此之前，曾在雪佛龙担任多个财务领导职务。Logan先生拥有30多年的能源行业经验，以及在合同制造和消费品行业内的丰富经验。洛根先生获得了康奈尔大学的工商管理硕士学位和学士学位。
- Thomas D. Logan is the Founder of Mirion, and has served as its Chief Executive Officer since 2005. He has served as a member of Mirion's Board of Directors since 2005 and as the Chairman of the Board since February 2025. Prior to joining Mirion, Mr. Logan served as Chief Executive Officer for Global Dosimetry Solutions, a radiation dosimetry provider, from 2004 to 2005. Prior to 2004, Mr. Logan served as President of BAF Energy, CFO of E M Solutions and of BVP, Inc. and prior to that, held various finance leadership positions at Chevron. Mr. Logan has more than 30 years of energy industry experience, as well as extensive experience within the contract manufacturing and consumer products industries. Mr. Logan received a M.B.A. and a B.S. from Cornell University.
- Emmanuelle Lee
Emmanuelle Lee自2011年起担任Mirion副总法律顾问，自2018年起担任总法律顾问和首席合规官。Lee女士之前的职位包括FrontRange Solutions（现为Ivanti）和PeopleSoft（现为甲骨文）的公司法律顾问职位，以及Ropers Majeski，Kohn & Bentley公司的律师。此外，她的职业生涯始于已故法国参议员泽维尔·德维尔潘的议会援助，他曾代表法国侨民，领导参议院外交、国防和武装部队委员会。
Emmanuelle Lee has served as Deputy General Counsel of Mirion since 2011 and General Counsel and Chief Compliance Officer since 2018. Ms. Lee's prior positions include corporate counsel positions with FrontRange Solutions (now Ivanti) and PeopleSoft (now Oracle), and attorney at law with the firm of Ropers Majeski, Kohn & Bentley. In addition, she started her career as a parliamentary aid to the late Xavier de Villepin, a French Senator who represented French expatriates and headed the Senate Committee for Foreign Affairs, Defense, and Armed Forces.- Emmanuelle Lee自2011年起担任Mirion副总法律顾问，自2018年起担任总法律顾问和首席合规官。Lee女士之前的职位包括FrontRange Solutions（现为Ivanti）和PeopleSoft（现为甲骨文）的公司法律顾问职位，以及Ropers Majeski，Kohn & Bentley公司的律师。此外，她的职业生涯始于已故法国参议员泽维尔·德维尔潘的议会援助，他曾代表法国侨民，领导参议院外交、国防和武装部队委员会。
- Emmanuelle Lee has served as Deputy General Counsel of Mirion since 2011 and General Counsel and Chief Compliance Officer since 2018. Ms. Lee's prior positions include corporate counsel positions with FrontRange Solutions (now Ivanti) and PeopleSoft (now Oracle), and attorney at law with the firm of Ropers Majeski, Kohn & Bentley. In addition, she started her career as a parliamentary aid to the late Xavier de Villepin, a French Senator who represented French expatriates and headed the Senate Committee for Foreign Affairs, Defense, and Armed Forces.
- Loic Eloy
Loic Eloy于2022年2月被任命为Mirion Nuclear & Safety Group总裁。Eloy先生于2015年加入Mirion，此前曾于2015年至2019年担任Mirion检测和测量（健康物理）部门副总裁，并于2019年至2022年担任Mirion辐射监测系统部门总裁。在通过收购Canberra Industries加入Mirion之前，Eloy先生曾于2012年至2015年担任Canberra Industries母公司Areva的商务总监，并于2008年至2012年担任Areva的财务和会计总监。在2008年之前，Eloy先生曾在西门子担任过多个财务和商务职位。
Loic Eloy was named Mirion Nuclear & Safety Group President in February 2022. Mr. Eloy joined Mirion in 2015 and previously held the roles of Vice President of Mirion's Detection and Measurement (Health Physics) Division from 2015 to 2019, and President of Mirion's Radiation Monitoring Systems Division from 2019 to 2022. Prior to joining Mirion through the acquisition of Canberra Industries, Mr. Eloy served as Commercial Director of Areva, the parent company of Canberra Industries, from 2012 to 2015, as well as Director of Finance and Accounting for Areva from 2008 to 2012. Prior to 2008, Mr. Eloy held various finance and commercial positions with Siemens.- Loic Eloy于2022年2月被任命为Mirion Nuclear & Safety Group总裁。Eloy先生于2015年加入Mirion，此前曾于2015年至2019年担任Mirion检测和测量（健康物理）部门副总裁，并于2019年至2022年担任Mirion辐射监测系统部门总裁。在通过收购Canberra Industries加入Mirion之前，Eloy先生曾于2012年至2015年担任Canberra Industries母公司Areva的商务总监，并于2008年至2012年担任Areva的财务和会计总监。在2008年之前，Eloy先生曾在西门子担任过多个财务和商务职位。
- Loic Eloy was named Mirion Nuclear & Safety Group President in February 2022. Mr. Eloy joined Mirion in 2015 and previously held the roles of Vice President of Mirion's Detection and Measurement (Health Physics) Division from 2015 to 2019, and President of Mirion's Radiation Monitoring Systems Division from 2019 to 2022. Prior to joining Mirion through the acquisition of Canberra Industries, Mr. Eloy served as Commercial Director of Areva, the parent company of Canberra Industries, from 2012 to 2015, as well as Director of Finance and Accounting for Areva from 2008 to 2012. Prior to 2008, Mr. Eloy held various finance and commercial positions with Siemens.
- Brian Schopfer
Brian Schopfer于2020年5月被任命为Mirion 首席财务官，并于2025年担任医疗集团总裁一职。2025年期间，Schopfer先生还负责监督公司的IT、采购/采购、并购和PEG职能。他最初于2015年加入Mirion，曾担任业务转型执行兼高级副总裁，之后于2018年加入Omnimax International，担任北美地区首席财务官。Schopfer先生于2019年3月重返Mirion。Schopfer先生之前的经验包括在美国都福集团内担任领导职务，例如2013年至2014年的财务规划和分析总监，以及2014年至2015年的HillPhoenix 首席财务官。
Brian Schopfer was named Mirion Chief Financial Officer in May 2020 and assumed the additional role of Medical Group President in 2025. During 2025 Mr. Schopfer was also responsible for overseeing the Company's IT, Sourcing/Procurement, M&A and PEG functions. Originally joining Mirion in 2015, he held the role of Executive and Senior Vice President of Business Transformation before joining Omnimax International as Chief Financial Officer of North America in 2018. Mr. Schopfer returned to Mirion in March 2019. Mr. Schopfer's prior experience includes leadership roles within the Dover Corporation such as Director of Financial Planning and Analysis from 2013 to 2014, and Chief Financial Officer of Hillphoenix from 2014 to 2015.- Brian Schopfer于2020年5月被任命为Mirion 首席财务官，并于2025年担任医疗集团总裁一职。2025年期间，Schopfer先生还负责监督公司的IT、采购/采购、并购和PEG职能。他最初于2015年加入Mirion，曾担任业务转型执行兼高级副总裁，之后于2018年加入Omnimax International，担任北美地区首席财务官。Schopfer先生于2019年3月重返Mirion。Schopfer先生之前的经验包括在美国都福集团内担任领导职务，例如2013年至2014年的财务规划和分析总监，以及2014年至2015年的HillPhoenix 首席财务官。
- Brian Schopfer was named Mirion Chief Financial Officer in May 2020 and assumed the additional role of Medical Group President in 2025. During 2025 Mr. Schopfer was also responsible for overseeing the Company's IT, Sourcing/Procurement, M&A and PEG functions. Originally joining Mirion in 2015, he held the role of Executive and Senior Vice President of Business Transformation before joining Omnimax International as Chief Financial Officer of North America in 2018. Mr. Schopfer returned to Mirion in March 2019. Mr. Schopfer's prior experience includes leadership roles within the Dover Corporation such as Director of Financial Planning and Analysis from 2013 to 2014, and Chief Financial Officer of Hillphoenix from 2014 to 2015.
- Alison Ulrich
Alison Ulrich于2022年4月被任命为Mirion的首席人力资源官。在担任Mirion全球人力资源总监之前，Alison负责构建和管理Mirion人力资源职能，以支持不断增长的员工基础，领导全球人力资源计划，并实施计划以提升整个组织的员工体验。在2004年加入Mirion之前，1999年至2003年在软件工程公司Inovis担任人力资源总监。
Alison Ulrich was named Chief Human Resources Officer of Mirion in April 2022. Previously serving as the Global HR Director for Mirion, Alison was responsible for building and managing the Mirion HR function to support the growing employee base, leading global HR initiatives, and implementing programs to elevate the employee experience across the organization. Prior to joining Mirion in 2004, was the Director of Human Resources at Inovis, a software engineering company, from 1999 to 2003.- Alison Ulrich于2022年4月被任命为Mirion的首席人力资源官。在担任Mirion全球人力资源总监之前，Alison负责构建和管理Mirion人力资源职能，以支持不断增长的员工基础，领导全球人力资源计划，并实施计划以提升整个组织的员工体验。在2004年加入Mirion之前，1999年至2003年在软件工程公司Inovis担任人力资源总监。
- Alison Ulrich was named Chief Human Resources Officer of Mirion in April 2022. Previously serving as the Global HR Director for Mirion, Alison was responsible for building and managing the Mirion HR function to support the growing employee base, leading global HR initiatives, and implementing programs to elevate the employee experience across the organization. Prior to joining Mirion in 2004, was the Director of Human Resources at Inovis, a software engineering company, from 1999 to 2003.